Inhibitor of differentiation Id2 is involved in the pathogenesis of angiotensin II-induced end-organ damage

被引:0
|
作者
Gratze, P
Dechend, R
Shagdarsuren, E
Park, JK
Wellner, M
Fiebeler, A
Zenclusen, A
Alenina, N
Bader, M
Zenke, M
Luft, FC
Muller, DN
机构
[1] Franz Volhard Clin, HELIOS, Berlin, Germany
[2] Hannover Med Sch, Dept Med Nephrol, D-3000 Hannover, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Max Delbruck Ctr Mol Med, Berlin, Germany
[5] Univ Aachen, Rhein Westfal TH Aachen, Sch Med, Aachen, Germany
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:893 / 893
页数:1
相关论文
共 50 条
  • [1] Inhibitor of differentiation Id2 is involved in the pathogenesis of angiotensin II-induced end-organ damage
    Gratze, P.
    Dechend, R.
    Shagdarsuren, E.
    Bader, M.
    Zenke, M.
    Dietz, R.
    Luft, F. C.
    Mueller, D. N.
    EUROPEAN HEART JOURNAL, 2006, 27 : 116 - 116
  • [2] Inhibitor of differentiation Id2 is involved in the pathogenesis of angiotensin II-induced endorgan damage.
    Gratze, P
    Dechend, R
    Shagdarsuren, E
    Park, JK
    Wellner, M
    Fiebeler, A
    Zenclusen, A
    Alenina, N
    Bader, M
    Zenke, M
    Luft, FC
    Mueller, DN
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 : 123 - 123
  • [3] Aldosterone synthase inhibitor FAD286 ameliorates angiotensin II-induced end-organ damage
    Fiebeler, A
    Nussberger, J
    Shagdarsuren, E
    Dechend, R
    Rong, S
    Al-Saadi, N
    Gapelyuk, A
    Schirdewan, A
    Wellner, M
    Jeng, A
    Webb, R
    Luft, FC
    Mueller, D
    CIRCULATION, 2004, 110 (17) : 101 - 101
  • [4] Aldosterone synthase inhibitor FAD286 ameliorates angiotensin II-induced end-organ damage
    Fiebeler, A
    Shagdarsuren, E
    Rong, S
    Al-Saadi, N
    Gapelyuk, A
    Schirdewan, A
    Dechend, R
    Wellner, M
    Jeng, AY
    Webb, RL
    Luft, FC
    Muller, DN
    HYPERTENSION, 2004, 44 (04) : 514 - 515
  • [5] Cardioprotective effects of n-3 PUFA in angiotensin II-induced end-organ damage
    Fischer, R.
    Qadri, F.
    Markovic, M.
    Gapelyuk, A.
    Safak, E.
    Gratze, P.
    Heuser, A.
    Schrirdewan, A.
    Luft, F. C.
    Schunk, W. H.
    Dechend, R.
    Mueller, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (46) : S2 - S2
  • [6] Cardioprotective effects of n-3 PUFA in angiotensin II-induced end-organ damage
    Fischer, Robert
    Markovic, Marija
    Qadri, Fatimunnisa
    Gapeljuk, Andrej
    Safak, Erdal
    Gratze, Petra
    Heuser, Arnd
    Schirdewan, Alexander
    Luft, Friedrich C.
    Schunck, Wolf-Hagen
    Dechend, Ralf
    Muller, Dominik N.
    HYPERTENSION, 2007, 50 (04) : E100 - E100
  • [7] n-3 PUFA as antiarrhythmic and cardioprotective agents in angiotensin II-induced end-organ damage
    Fischer, R.
    Schirdewan, A.
    Markovic, M.
    Heuser, A.
    Safak, E.
    Gapelyuk, A.
    Voelker, B.
    Schunck, W. H.
    Mueller, D. N.
    Dechend, R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 768 - 768
  • [8] Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension
    Khan, Nayaab S.
    Song, Chi Young
    Thirunavukkarasu, Shyamala
    Fang, Xiao R.
    Bonventre, Joseph V.
    Malik, Kafait U.
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (02) : 258 - 265
  • [9] The role of angiotensin II in hypertension and end-organ damage
    Pool, JL
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 4 - 8
  • [10] Effect of bosentan on NF-κB, inflammation, and tissue factor in angiotensin II-induced end-organ damage
    Muller, DN
    Mervaala, EMA
    Schmidt, F
    Park, JK
    Dechend, R
    Genersch, E
    Breu, V
    Löffler, BM
    Ganten, D
    Schneider, W
    Haller, H
    Luft, FC
    HYPERTENSION, 2000, 36 (02) : 282 - 290